Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis

Summary

Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis is a doctoral thesis^[1].

Key Facts

• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis authored Pirooz Zareie^[2].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's instance of is recorded as doctoral thesis^[3].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's publisher is recorded as Open Access Repository Victoria University of Wellington^[4].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's DOI is recorded as 10.26686/WGTN.17065139^[5].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's language of work or name is recorded as English^[6].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's country of origin is recorded as New Zealand^[7].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's publication date is recorded as +2017-01-01T00:00:00Z^[8].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's main subject is recorded as antipsychotics^[9].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's main subject is recorded as multiple sclerosis^[10].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's title is recorded as Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis^[11].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's copyright holder is recorded as Pirooz Zareie^[12].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's thesis submitted to is recorded as Victoria University of Wellington^[13].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's on focus list of Wikimedia project is recorded as NZThesisProject^[14].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's copyright status is recorded as copyrighted^[15].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's thesis committee member is recorded as Anne La Flamme^[16].
• Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's thesis committee member is recorded as Melanie J. McConnell^[17].

Body

Designation and Status

Investigating the mechanism by which the atypical antipsychotic clozapine reduces disease in experimental autoimmune encephalomyelitis's instance of is recorded as doctoral thesis^[3].